BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 8754863)

  • 1. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of drug resistance of Mycobacterium tuberculosis by methods of proportions and absolute concentrations].
    Golyshevskaia VI; Sevast'ianova EV; Voronina GA
    Probl Tuberk; 2001; (3):51-3. PubMed ID: 11508236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
    Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
    Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis].
    Vasil'eva IA; Chernousova LN; Zasedatelev AS; Sobolev AIu; Mikhaĭlovich VM
    Probl Tuberk; 2002; (6):21-4. PubMed ID: 12227044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
    Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
    J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary drug resistant tuberculosis in Puerto Rico.
    Zack MB; Figueroa-Lebrón RE
    Bol Asoc Med P R; 1974 Nov; 65(11):262-6. PubMed ID: 4217187
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Occurence of primary resistance in hospital patients with respiratory tuberculosis].
    Serdarević H; Bogdanović M; Travnik H; Simeonov L
    Tuberkuloza; 1966; 18(1-3):220-7. PubMed ID: 16296090
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
    Shaĭkhaev AIa; Naumov VN
    Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates].
    Zhukova MP
    Probl Tuberk; 1998; (4):4-5. PubMed ID: 9771024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin].
    Isakova ZhT; Pak OA; Iusupova EIu; Myrzaliev BB; Chubakov TCh; Goncharova ZA; Tumashova AF; Kozhomkulov MD; Kozhomkulov DK; Alisherov ASh; Friedland J; Aldashev AA
    Probl Tuberk Bolezn Legk; 2005; (8):50-3. PubMed ID: 16209022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug resistant tuberculosis in Estonia.
    Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention.
    Almeida D; Rodrigues C; Udwadia ZF; Lalvani A; Gothi GD; Mehta P; Mehta A
    Clin Infect Dis; 2003 Jun; 36(12):e152-4. PubMed ID: 12802779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.